✦ LIBER ✦

Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

✍ Scribed by D. Kürktschiev; S. Subat; D. Adler; K.-U. Schentke

Book ID: 118566252
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 249 KB
Volume: 18
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80284-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid therapy in primary

Ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic

Cost-effectiveness of ursodeoxycholic ac

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ Tousif Pasha; Jenny Heathcote; Sherine Gabriel; Karen Cauch-Dudek; Roberta Jorge 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Cholesterol-lowering effect of ursodeoxy

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

✍ Renée E. Poupon; Khadija Ouguerram; Yves Chrétien; Claudine Verneau; Eveline Esc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids

Serum bile acids in primary biliary cirr

Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy

✍ Renée E. Poupon; Yves Chrétien; Raoul Poupon; Gustav Paumgartner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Cholic acid and ursodeoxycholic acid the

Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ S. Güldütuna; M. Leuschner; N. Wunderlich; A. Nickel; S. Bhatti; K. Hübner; U. L 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 441 KB

Biliary bile acids in primary biliary ci

Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid

✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Santiago Munoz; Guada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed